Marinus Pharmaceuticals (MRNS) Short Interest Ratio & Short Volume $0.55 0.00 (-0.16%) As of 02/11/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marinus Pharmaceuticals Short Interest DataMarinus Pharmaceuticals (MRNS) has a short interest of 2.18 million shares. This marks a -6.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 1.79 million shares to cover all short positions.Current Short Interest2,180,000 sharesPrevious Short Interest2,320,000 sharesChange Vs. Previous Month-6.03%Dollar Volume Sold Short$1.18 millionShort Interest Ratio1.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares55,220,000 sharesPercentage of Shares Shorted3.95%Today's Trading Volume260 sharesAverage Trading Volume1,786,443 sharesToday's Volume Vs. Average0% Short Selling Marinus Pharmaceuticals? Sign up to receive the latest short interest report for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRNS Short Interest Over TimeMRNS Days to Cover Over TimeMRNS Percentage of Float Shorted Over Time Marinus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20252,180,000 shares $1.18 million -6.0%N/A1.2 $0.54 1/15/20252,320,000 shares $1.25 million -35.9%N/A0.7 $0.54 12/31/20243,620,000 shares $1.94 million -16.0%N/A1.1 $0.54 12/15/20244,310,000 shares $1.13 million -1.6%N/A1.6 $0.26 11/30/20244,380,000 shares $1.42 million -4.6%N/A1.7 $0.32 11/15/20244,590,000 shares $1.39 million -18.9%N/A1.8 $0.30 10/31/20245,660,000 shares $1.71 million +62.2%N/A2.4 $0.30 10/15/20243,490,000 shares $6.07 million +8.4%N/A6.7 $1.74 9/30/20243,220,000 shares $5.67 million +11.0%N/A5.8 $1.76 9/15/20242,900,000 shares $4.35 million +5.8%N/A4.2 $1.50 Get the Latest News and Ratings for MRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,740,000 shares $3.84 million +2.2%N/A4 $1.40 8/15/20242,680,000 shares $3.27 million +6.8%N/A3.3 $1.22 7/31/20242,510,000 shares $3.51 million -7.0%N/A2.5 $1.40 7/15/20242,700,000 shares $3.81 million -42.4%N/A2.2 $1.41 6/30/20244,690,000 shares $5.49 million +1.1%N/A2 $1.17 6/15/20244,640,000 shares $6.80 million -9.7%N/A2.1 $1.47 5/31/20245,140,000 shares $7.30 million +5.1%N/A2.4 $1.42 5/15/20244,890,000 shares $6.50 million -2.2%N/A2.4 $1.33 4/30/20245,000,000 shares $7.05 million +10.6%N/A2.7 $1.41 4/15/20244,520,000 shares $5.88 million +30.3%N/A2.7 $1.30 3/31/20243,470,000 shares $31.37 million -2.8%N/A7.7 $9.04 3/15/20243,570,000 shares $33.52 million +4.1%N/A8.2 $9.39 2/29/20243,430,000 shares $32.59 million -3.9%N/A7.9 $9.50 2/15/20243,570,000 shares $35.70 million -1.4%N/A9.1 $10.00 1/31/20243,620,000 shares $35.26 million -6.0%N/A8.8 $9.74 1/15/20243,850,000 shares $37.73 million -12.3%N/A8.8 $9.80 12/31/20234,390,000 shares $47.72 million +12.0%N/A10.1 $10.87 12/15/20233,920,000 shares $33.67 million -1.0%N/A8.7 $8.59 11/30/20233,960,000 shares $26.65 million -13.0%N/A8 $6.73 11/15/20234,550,000 shares $28.03 million +2.7%N/A8.1 $6.16 10/31/20234,430,000 shares $30.74 million +15.1%N/A6.6 $6.94 10/15/20233,850,000 shares $26.49 million +6.1%N/A5.8 $6.88 9/30/20233,630,000 shares $29.22 million -4.2%N/A5.4 $8.05 9/15/20233,790,000 shares $23.12 million +5.6%N/A5.3 $6.10 8/31/20233,590,000 shares $25.52 million +7.5%N/A4.3 $7.11 8/15/20233,340,000 shares $20.47 million +14.0%N/A4 $6.13 7/31/20232,930,000 shares $31.18 million -9.3%N/A3.5 $10.64 7/15/20233,230,000 shares $31.85 million +17.0%N/A3.7 $9.86 6/30/20232,760,000 shares $29.97 million +54.2%N/A3 $10.86 6/15/20231,790,000 shares $17.54 million +17.0%N/A2.1 $9.80Trump’s Secret Weapon (Ad)The Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump and Elon Musk isn't just political theater. It's a direct threat to the stability of markets, the dollar, and your life savings. When two of the most powerful men in America go to war, the economy loses.Click here to get your FREE Presidential Transition Guide now 5/31/20231,530,000 shares $10.88 million -16.4%N/A2.2 $7.11 5/15/20231,830,000 shares $15.77 million +19.6%N/A2.9 $8.62 4/30/20231,530,000 shares $13.92 million -19.9%N/A2.7 $9.10 4/15/20231,910,000 shares $14.11 million +7.3%N/A3.8 $7.39 3/31/20231,780,000 shares $12.28 million +17.1%N/A3.8 $6.90 3/15/20231,520,000 shares $10.06 million +7.0%N/A3.5 $6.62 2/28/20231,420,000 shares $9.80 million +6.8%N/A3.6 $6.90 2/15/20231,330,000 shares $9.02 million +2.3%N/A3.6 $6.78 1/31/20231,300,000 shares $8.26 million -7.8%N/A3.1 $6.35 1/15/20231,410,000 shares $6.97 million +3.7%N/A3.8 $4.94 12/30/20221,360,000 shares $5.41 million +5.4%N/A4.2 $3.98 12/15/20221,290,000 shares $5.29 million +1.6%N/A4 $4.10 11/30/20221,270,000 shares $6.08 million -1.6%N/A4 $4.79 11/15/20221,290,000 shares $6.18 million -12.2%N/A4.6 $4.79 10/31/20221,470,000 shares $8.45 million +6.5%4.5%5.5 $5.75 10/15/20221,380,000 shares $7.40 million -5.5%4.3%6.3 $5.36 9/30/20221,460,000 shares $9.71 million +29.2%4.5%7 $6.65 9/15/20221,130,000 shares $7.55 million +3.7%3.5%4 $6.68 8/31/20221,090,000 shares $7.59 million +17.6%3.4%3.7 $6.96 8/15/2022927,200 shares $5.27 million -7.3%2.9%2.8 $5.68 7/31/20221,000,000 shares $5.57 million No Change3.1%2.9 $5.57 7/15/20221,000,000 shares $5.71 million -1.0%3.1%2.9 $5.71 6/30/20221,010,000 shares $4.89 million -58.3%3.1%3 $4.84 6/15/20222,420,000 shares $10.45 million +30.1%7.5%7 $4.32 5/31/20221,860,000 shares $9.02 million +13.4%5.8%4.6 $4.85 5/15/20221,640,000 shares $9.28 million +18.0%5.1%4.2 $5.66 4/30/20221,390,000 shares $9.20 million +8.6%4.3%3.7 $6.62 4/15/20221,280,000 shares $9.98 million -9.9%4.0%3.5 $7.80 3/31/20221,420,000 shares $13.28 million -6.6%4.4%4.1 $9.35 3/15/20221,520,000 shares $11.10 million +20.6%4.7%4.7 $7.30 2/28/20221,260,000 shares $9.85 million +2.4%3.9%7.5 $7.82 2/15/20221,230,000 shares $14.76 million +17.1%3.8%7.8 $12.00 1/31/20221,050,000 shares $10.71 million No Change3.5%7.4 $10.20 1/15/20221,050,000 shares $11.62 million +1.9%3.2%7.6 $11.07 12/31/20211,030,000 shares $12.24 million -7.2%3.2%7.2 $11.88 12/15/20211,110,000 shares $11.70 million -1.8%3.4%7.1 $10.54 11/30/20211,130,000 shares $12.55 million +1.8%3.5%6.6 $11.11 11/15/20211,110,000 shares $13.91 million -16.5%3.4%6.2 $12.53 10/29/20211,330,000 shares $15.30 million +3.9%4.1%6.2 $11.50 10/15/20211,280,000 shares $14.67 million -65.2%4.0%5.9 $11.46 9/30/20213,680,000 shares $41.88 million +1.7%11.4%17.3 $11.38 9/15/20213,620,000 shares $41.01 million -3.7%11.2%15.5 $11.33 8/31/20213,760,000 shares $46.47 million -1.1%11.7%16.6 $12.36 8/13/20213,800,000 shares $46.40 million -0.5%11.8%17.2 $12.21 7/30/20213,820,000 shares $56.15 million -0.5%11.0%18 $14.70 7/15/20213,840,000 shares $61.82 million -4.5%11.1%18.1 $16.10 6/30/20214,020,000 shares $72.12 million -0.7%11.6%18 $17.94 6/15/20214,050,000 shares $71.85 million -6.9%11.7%19.5 $17.74 5/28/20214,350,000 shares $73.17 million -5.4%12.5%18.2 $16.82 5/14/20214,600,000 shares $70.20 million +2.5%13.3%16.5 $15.26Trump’s Secret Weapon (Ad)The Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump and Elon Musk isn't just political theater. It's a direct threat to the stability of markets, the dollar, and your life savings. When two of the most powerful men in America go to war, the economy loses.Click here to get your FREE Presidential Transition Guide now 4/30/20214,490,000 shares $66.68 million +0.7%12.9%15.7 $14.85 4/15/20214,460,000 shares $66.23 million +0.5%12.8%14.6 $14.85 3/31/20214,440,000 shares $63.54 million +5.2%13.1%13.3 $14.31 3/15/20214,220,000 shares $67.86 million -0.2%12.5%10.9 $16.08 2/26/20214,230,000 shares $63.83 million +1.2%13.1%9 $15.09 2/12/20214,180,000 shares $62.66 million -2.1%12.9%8.4 $14.99 1/29/20214,270,000 shares $53.50 million -1.8%13.1%8.1 $12.53 1/15/20214,350,000 shares $55.38 million -17.6%13.3%8.1 $12.73 12/31/20205,280,000 shares $65.10 million +6.7%16.4%9.3 $12.33 12/15/20204,950,000 shares $64.89 million No Change15.4%7.1 $13.11 11/30/20204,950,000 shares $72.47 million +1.0%17.9%3.4 $14.64 11/15/20204,900,000 shares $73.35 million +6.8%17.7%3.6 $14.97 10/30/20204,590,000 shares $61.32 million +19.2%16.6%3.4 $13.36 10/15/20203,850,000 shares $55.79 million +4.6%14.0%2.8 $14.49 9/30/20203,680,000 shares $47.29 million -75.7%12.7%2.7 $12.85 9/15/202015,120,000 shares $193.54 million +2.2%53.6%12.4 $12.80 8/31/202014,800,000 shares $114.85 million +29.8%N/A8 $7.76 8/14/202011,400,000 shares $81.62 million +6.8%N/A6.7 $7.16 7/31/202010,670,000 shares $71.70 million +28.9%N/A6.7 $6.72 7/15/20208,280,000 shares $66.90 million +8.7%N/A6 $8.08 6/30/20207,620,000 shares $77.42 million +14.1%N/A6.6 $10.16 6/15/20206,680,000 shares $63.86 million +0.3%N/A6.4 $9.56 MRNS Short Interest - Frequently Asked Questions What is Marinus Pharmaceuticals' current short interest? Short interest is the volume of Marinus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 2,180,000 shares of MRNS short. Learn More on Marinus Pharmaceuticals' current short interest. What is a good short interest ratio for Marinus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNS shares currently have a short interest ratio of 1.0. Learn More on Marinus Pharmaceuticals's short interest ratio. Is Marinus Pharmaceuticals' short interest increasing or decreasing? Marinus Pharmaceuticals saw a decline in short interest in January. As of January 31st, there was short interest totaling 2,180,000 shares, a decline of 6.0% from the previous total of 2,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Marinus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Marinus Pharmaceuticals: Neumora Therapeutics, Inc. (20.95%), Theratechnologies Inc. (1.49%), Contineum Therapeutics, Inc. (4.50%), Kyverna Therapeutics, Inc. (13.20%), Atossa Therapeutics, Inc. (6.14%), Invivyd, Inc. (10.39%), Procaps Group S.A. (0.12%), Sagimet Biosciences Inc. (15.20%), IO Biotech, Inc. (0.35%), Cabaletta Bio, Inc. (12.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Marinus Pharmaceuticals stock? Short selling MRNS is an investing strategy that aims to generate trading profit from Marinus Pharmaceuticals as its price is falling. MRNS shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marinus Pharmaceuticals? A short squeeze for Marinus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNS, which in turn drives the price of the stock up even further. How often is Marinus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNS, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies NMRA Short Interest THTX Short Interest CTNM Short Interest KYTX Short Interest ATOS Short Interest IVVD Short Interest PROC Short Interest SGMT Short Interest IOBT Short Interest CABA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRNS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marinus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marinus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
